期刊文献+

硫酸乙酰肝素/肝素的药用价值研究进展 被引量:5

Drug potential of heparan sulfate/heparin:research advances
下载PDF
导出
摘要 硫酸乙酰肝素(HS)和肝素(HP)是由重复的二糖单位组成的高度硫酸化的结构多样性的多糖链,HS通过与蛋白质的相互作用参与了许多相关生物学功能和病理过程的调控,并在其中扮演了重要作用。HS也在抗病毒方面显示出了潜在药用价值。作为HS的特殊结构形式的HP已在临床上被广泛用作抗凝药物使用,并在抗癌、抗炎方面显示出了药用应用前景。本文针对HS/HP在抗凝、抗癌、抗炎和抗病毒方面的药用价值研究进展进行综述。 Heparan sulfate (HS) and heparin (HP) are highly sulfated and heterogeneous polysaccharides composed of repeating disaccharide units. HS takes part in regulation of many related biological functions through its interaction with proteins and plays an important role in them. HS is also shown to have promising perspectives as a potential antivirus agent. As a special structure type of HS, HP is also widely used as the clinical anticoagulant drug and demonstrated to be a promising candidate for anticancer and anti-inflammatory drugs. Progress of the research in the areas of anticoagulant, anticancer, anti-inflammatory and antivirus activity of HS/HP and their chemoenzymatic synthesis is summarized in this review.
作者 周跃钢
出处 《国际药学研究杂志》 CAS CSCD 2014年第4期393-399,共7页 Journal of International Pharmaceutical Research
基金 国家留学基金委访问学者奖学金资助项目(2006102368) 日本科学与技术国际交流协会资助项目(2007)
关键词 硫酸乙酰肝素 肝素 生化药物 heparan sulfate heparin biochemical drag
  • 相关文献

参考文献57

  • 1Mizumoto S,Kitagawa h,Sugahara K.Chapter 7:biosynthesis ofheparin and heparan sulfate [M].Garg HG,Linhardt RJ,HalesCA,ed.Chemistry and Biology of Heparin and Heparan sulfate.Oxford:Elsevier Ltd,2005:203-243.
  • 2Dulaney SB,Huang X.Strategies in synthesis of heparin/heparansulfate oligosaccharides:2000-present [j ].Adv Carbohydr ChemBiochem,2012,67:95-136.
  • 3陈武.多元模态逻辑中的范本特姆—罗森定理[J].西南大学学报(自然科学版),2013,35(12):159-164. 被引量:4
  • 4Chappell EP,Liu J.Use of biosynthetic enzymes in heparin andheparan sulfate synthesis [j].Bioorg Med Chem,2013,21(16):4786-4792.
  • 5Li JP,Vlodavsky I.Heparin,heparan sulfate and heparanase ininflammatory reactions [j].Throm Haemost,2009,102(5):823-828.
  • 6Xu Y,Masuko S,Takieddin M,et al.Chemoenzymatic synthesis ofhomogeneous ultralow molecular weight heparins [J].Science,2011,334(6055):498-501.
  • 7Rek A,Krenn E,Kungl,AJ.Therapeutically targeting protein-glycan interactions[j].Br J Pharmacol,2009,157(5):686-694.
  • 8Bishop JR,Schuks M,Esko JD.Heparan sulphate proteoglycansfine-tune mammalian physiology [J].Nature,2007,446(7139):1030-1037.
  • 9Masuko S,Linhardt RJ.Chemoenzymatic synthesis of the nextgeneration of ultralow MW heparin therapeutics [J].Fut Med Chem,2012,4(3):289-296.
  • 10Bendas G,Borsig L.Cancer cell adhesion and metastasis:sele-ctins,integrins,and the inhibitory potential of heparins [J ].Int J Cell Biol,2012,2012:676731.

二级参考文献60

  • 1Sang-Ho Park,Napapan Kangwan,Jong-Min Park,Eun-Hee Kim,Ki Baik Hahm.Non-microbial approach for Helicobacter pylori as faster track to prevent gastric cancer than simple eradication[J].World Journal of Gastroenterology,2013,19(47):8986-8995. 被引量:6
  • 2Akhtar J, Tiwari V, Oh MJ, et al. HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium. Invest Ophthalrnol Vis Sci, 2008, 49(9): 4026-35.
  • 3Satoh T, Arii J, Suenaga T, et al. PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell, 2008, 132(6): 935-44.
  • 4Janas AM, Dong C, Wang J-H, et al. Productive infection of human immunodeficiency virus type 1 in dendritic cells requires fusion-mediated viral entry. Virology, 2008, 375(2): 442-51.
  • 5Marsh M, Helenius A. Virus entry: open sesame. 2006, Cell, 124(4): 729-40.
  • 6Harrison SC. Viral membrane fusion. Nat Struct Mol Biol, 2008, 15(7): 690-8.
  • 7Campadelli-Fiume G, Arnasio M, Avitabile E, et al. The multipartite system that mediates entry of herpes simplex virus into the cell. Rev Med Virol, 2007, 17(5): 313-26.
  • 8Akhtar J, Shukla D. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J, 2009, 276(24): 7228-36.
  • 9Sapp M, Day PM. Structure, attachment and entry of polyoma- and papillomavimses. Virology, 2009, 384(2): 400-9.
  • 10Sapp M, Bienkowska-Haba M. Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus. FEBS J, 2009, 276(24): 7206-16.

共引文献35

同被引文献69

  • 1方勤 ,Sanket Shah ,Yuyao Liang ,Z.H.Zhou .草鱼呼肠孤病毒的三维重构与衣壳蛋白特性[J].中国科学(C辑),2005,35(3):231-237. 被引量:14
  • 2Mizumoto S, Kitagawa h, Sugahara K. Chapter 7:Biosynthesis of heparin and heparan sulfate [M]//Garg HG,Linhardt RJ, Hales CA, eds. Chemistry and biology of heparin and heparan sulfate. Oxford : Elsevier Ltd, 2005 : 203-243.
  • 3Chappell El?, Liu J. Use of biosynthetic enzymes in heparin and heparan sulfate synthesis[J]. Bioorg Med Chem, 2013, 21 (16) :4786-4792.
  • 4Dulaney SB, Huang X. Strategies in synthesis of heparin/heparan sulfate oligosaccharides: 2000-resent [J]. Adv Carbohydr Chem Biochem, 2012, 67:95-136.
  • 5Xu Y, Masuko S, Takieddin M, eta!. Chemoenzymmic synthesis of homogeneous ultralow molecular weight heparins[J ]. Science, 2011, 334(6055) :498-501.
  • 6Liu J, Linhardt RJ. Chemoenzymatie synthesis of heparin sulfateand hepafin[J]. NProd Rep, 2014, 31(12):1676-1685.
  • 7Li JP, Vlodavsky I. Heparin, heparan sulfate and heparanase in inflammatory reaetions[J]. Throm Haemost, 2009, 102(5): 823-828.
  • 8Sugiura N, Baba Y, Kawaguchi Y, et ol. Glucuronyhransferase activity of KfiC from Eseherichia coli strain K5 requires associ- ation of KfiA[J]. JBiol Chem, 2010, 285(3):1597-1606.
  • 9Chavaroche AA, van den Brock LA, Springer J, et al. Analysis of the polymerization initiation and activity of Pasteurella mul- tocida heparosan synthase PmHS2, an enzyme with glycosy- ltransferase and UDP-sugar hydrolase activity[J]. J Biol Chem, 2011, 286(3): 1777-85.
  • 10Chavaroehe AA, van den Brock LA, Boeriu C, et al. Synthesis of heparosan oligosaccharides by Pasteurella muhocida PmHS2 single-action transferascs[J] Appl Mierobiol Biotechnol, 2012, 95(5) : 1199-1210.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部